Placental insulin-mTOR and stress-inflammatory signaling patterns are associated with childhood adiposity

Ellen C Francis1, Kristen E Boyle2,3, Lauren E Gyllenhammer4

  • 1Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey, United States. Ellen.Francis@Rutgers.edu.

BMC Medicine
|May 8, 2026
PubMed

Insights

Placental signaling patterns influence childhood adiposity. One pattern linked to insulin and energy sensing was associated with lower body fat, while a stress-inflammatory pattern correlated with higher body fat and metabolic changes.

Area of Science:

  • Reproductive biology and developmental origins of health and disease.
  • Endocrinology and metabolic health research.
  • Placental biology and fetal programming.

Background:

  • Placental signaling pathways are crucial for nutrient transport and fetal growth, impacting offspring metabolic health.
  • Previous research often examined single placental markers, limiting understanding of coordinated pathway activity.
  • Investigating combined placental signaling patterns offers deeper insights into offspring health outcomes.

Purpose of the Study:

  • To identify latent patterns across placental nutrient signaling pathways.
  • To assess associations between these placental patterns and early childhood adiposity (% fat mass).
  • To explore links between adiposity-associated patterns and metabolic biomarkers in early childhood.

Main Methods:

  • Quantified 33 placental signaling proteins and their phosphorylation ratios in 108 mother-child pairs.
  • Utilized unsupervised methods to identify latent signaling patterns in placental villus tissue.
  • Applied LASSO and multivariable regression to analyze associations with childhood % fat mass and metabolic markers.

Main Results:

  • Identified two distinct placental signaling patterns associated with childhood % fat mass.
  • An insulin-mTOR-energy sensing pattern correlated with lower % fat mass and higher adiponectin.
  • A stress-inflammatory MAPK pattern correlated with higher % fat mass, leptin, and triglycerides.

Conclusions:

  • Specific placental signaling patterns are linked to childhood adiposity and metabolic profiles.
  • These findings highlight the importance of examining coordinated placental pathway activity.
  • Understanding these placental patterns may illuminate the early origins of adiposity and metabolic health.
Abstract

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...